8-K: OSR Holdings Amends White Lion Capital Agreements

OSR Holdings, Inc. amended its agreements with White Lion Capital, LLC, requiring stockholder approval for certain transactions by September 19, 2025, or facing significant penalties.

Summary

• OSR Holdings, Inc. (the Company) entered into Amendment No. 1 to its Note Purchase Agreement and Amendment No. 1 to its Common Stock Purchase Warrant with White Lion Capital, LLC, effective June 30, 2025.
• The amendments require the Company to convene a stockholder meeting prior to September 19, 2025, to seek approval for transactions with White Lion Capital, including the issuance of securities exceeding the 19.99% Nasdaq Rule 5635 Exchange Cap.
• Failure to take the necessary actions to convene the meeting and file proxy materials by the deadline will constitute a material breach.
• Under the Note Purchase Agreement, this breach would trigger liquidated damages of $400,000 payable immediately in cash to White Lion Capital.
• Under the Common Stock Purchase Warrant, this breach would allow White Lion Capital, at its sole discretion, to immediately adjust the warrant's exercise price to $0.01.
• If the Company takes the necessary actions, failure to obtain stockholder approval will not constitute a breach or default.

Sentiment

Score: 3

Explanation: The filing indicates increased financial and dilutive risks for the company due to new, stringent conditions and penalties imposed by an investor. While the company can avoid breach by taking necessary actions, the potential for significant financial penalties ($400,000) and severe warrant price adjustment ($0.01) if procedural deadlines are missed represents a negative development. It suggests the company is under pressure from its financing partner.

Positives

• The amendments clarify provisions regarding the exchange cap and ensure consistency across agreements with White Lion Capital.
• The Company is explicitly protected from breach or default if it takes the necessary actions to convene the stockholder meeting, even if stockholder approval is not ultimately obtained.

Negatives

• The Company faces a potential penalty of $400,000 in liquidated damages if it fails to convene a stockholder meeting and file necessary proxy materials by September 19, 2025.
• Failure to meet the deadline for the stockholder meeting could also lead to the exercise price of the Common Stock Purchase Warrant being immediately adjusted to $0.01 at White Lion Capital's discretion, potentially leading to significant dilution if exercised.
• The requirement for stockholder approval for transactions exceeding the 19.99% Nasdaq Rule 5635 Exchange Cap indicates that previous or planned issuances to White Lion Capital might be substantial relative to the Company's outstanding shares.

Risks

• Financial Penalty: Risk of incurring a $400,000 liquidated damages payment if the Company fails to take necessary actions to convene a stockholder meeting by September 19, 2025.
• Warrant Price Adjustment/Dilution: Risk of the Common Stock Purchase Warrant exercise price being reduced to $0.01, potentially leading to significant dilution for existing shareholders if White Lion Capital exercises the warrant at this reduced price.
• Regulatory Compliance: Failure to obtain stockholder approval for issuances exceeding the Nasdaq Rule 5635 Exchange Cap could lead to non-compliance issues with Nasdaq listing rules, although the filing states failure to obtain approval is not a breach if actions are taken. The risk is more about the process of getting approval.
• Shareholder Disapproval: Risk that stockholders may not approve the transactions, which, while not a breach, could complicate future financing or strategic initiatives with White Lion Capital.

Future Outlook

The Company is required to convene a meeting of its stockholders prior to September 19, 2025, to seek approval for various transactions and security issuances related to its agreements with White Lion Capital. This indicates a near-term focus on corporate governance and shareholder engagement to ensure compliance and avoid penalties.

Management Comments

• By: /s/ Kuk Hyoun Hwang Name: Kuk Hyoun Hwang Title: Chief Executive Officer
• Acknowledged and accepted by the Buyer: WHITE LION CAPITAL, LLC, DBA WHITE LION GBM INNOVATION FUND By: /s/ Yash Thukral Name: Yash Thukral Title: Managing Director

Industry Context

This filing reflects a common practice in capital markets where companies, particularly those with ongoing financing arrangements, must ensure compliance with exchange rules (like Nasdaq's 19.99% cap) regarding the issuance of securities. The inclusion of liquidated damages and potential warrant price adjustments highlights the leverage and protective measures institutional investors like White Lion Capital often build into their financing agreements to ensure corporate compliance and protect their investment. Such clauses are typical in equity line of credit or convertible debt arrangements, especially for smaller or emerging growth companies.

Comparison to Industry Standards

• The 19.99% Nasdaq Rule 5635 Exchange Cap is a standard regulatory threshold for public companies listed on Nasdaq, requiring shareholder approval for issuances exceeding this limit to prevent significant dilution without investor consent. Many companies engaging in equity financing or convertible debt deals structure their transactions to either stay below this cap or explicitly seek shareholder approval when exceeding it.
• The inclusion of liquidated damages ($400,000) for failure to meet a procedural deadline (convening a shareholder meeting) is a strong protective measure for the investor (White Lion Capital). While specific amounts vary, such penalty clauses are common in financing agreements to incentivize compliance.
• The provision allowing the warrant exercise price to be adjusted to $0.01 upon a procedural breach is an aggressive protective measure for the investor, significantly increasing their potential upside and leverage, and is more severe than typical anti-dilution clauses which usually adjust for stock splits or dividends, not procedural defaults. This type of clause is often seen in distressed financing or highly speculative investments.

Corporate Governance

Related Party Transactions

• The amendments pertain to agreements with White Lion Capital, LLC, which is a significant investor (Buyer/Holder) in OSR Holdings, Inc., making these related party transactions in the context of investor relations and financing.

Stakeholder Impact

• Shareholders: Potential for significant dilution if the Common Stock Purchase Warrant exercise price is adjusted to $0.01 due to a procedural breach. Shareholders will also be required to vote on the transactions, giving them a direct say in the company's financing strategy.
• Company Management: Faces increased pressure and a strict deadline (September 19, 2025) to ensure compliance with the new terms to avoid substantial financial penalties and adverse warrant adjustments.
• White Lion Capital, LLC: Gains stronger protective clauses, including liquidated damages and a potential significant reduction in warrant exercise price, enhancing their position and mitigating risks associated with the Company's compliance.

Next Steps

• OSR Holdings, Inc. must take all necessary actions, including filing proxy materials, to convene a meeting of its stockholders prior to September 19, 2025.
• The purpose of the meeting is to obtain stockholder approval for transactions with White Lion Capital, including the issuance of securities exceeding the Nasdaq Rule 5635 Exchange Cap.

Key Dates

Recommendation

The filing reveals new, stringent conditions and significant potential penalties for OSR Holdings, including a $400,000 liquidated damages payment and a drastic reduction in warrant exercise price to $0.01, if the company fails to meet a procedural deadline for stockholder approval. While the company can avoid breach by taking necessary actions, the introduction of such severe downside risks for procedural non-compliance, coupled with the implication of substantial prior or planned dilution (requiring approval for exceeding the 19.99% Nasdaq cap), suggests a precarious financial position and significant leverage held by the financing partner. This increases the risk profile for existing shareholders and indicates potential future dilution, making the stock a 'sell' for a seasoned investor.

Keywords

OSR Holdings, White Lion Capital, Note Purchase Agreement, Common Stock Purchase Warrant, SEC filing, 8-K, Nasdaq Rule 5635, Exchange Cap, Stockholder Approval, Liquidated Damages, Equity Line of Credit, Corporate Governance, Financing, Dilution